Creso Pharma subsidiary Mernova secures new purchase orders and launches new products
The new purchase orders include a second order from Ontario Cannabis Store and a third from Yukon Liquor Corporation and these highlight an ongoing shift towards a recurring revenue model.
A new larger one-ounce bag product segment allows consumers to secure product at a competitive price.
Creso Pharma Ltd’s (ASX:CPH) (FRA:1X8) wholly-owned Canadian subsidiary, Mernova Medicinal Inc has secured new purchase orders (POs) with a total value of C$145,192 (A$150,770) from the Ontario Cannabis Store (OCS) and Yukon Liquor Corporation.
The new POs include a second from OCS and a third from Yukon Liquor Corp and highlight an ongoing shift towards a recurring revenue model for Creso Pharma.